Dissecting transposable elements and endogenous retroviruses upregulation by HDAC inhibitors in leiomyosarcoma cells:
Nicolò Gualandi1, Martina Minisini1, Alessio Bertozzo1
1Department of Medicine, Università degli Studi di Udine, P.le Kolbe 4, 33100 Udine, Italy.
Abstract:
Transposable elements (TEs) are of interest as immunomodulators for cancer therapies. TEs can fold into dsRNAs that trigger the interferon response. Here, we investigated the effect of different HDAC inhibitors (HDACIs) on the expression of TEs in leiomyosarcoma cells. Our data show that endogenous retroviruses (ERVs), especially ERV1 elements, are upregulated after treatment with HDAC1/2/3-specific inhibitors. Surprisingly, the interferon response was not activated. We observed an increase in A-to-I editing of upregulated ERV1. This could have an impact on the stability of dsRNAs and the activation of the interferon response. We also found that H3K27ac levels are increased in the LTR12 subfamilies, which could be regulatory elements controlling the expression of proapoptotic genes such as TNFRSF10B. In summary, we provide a detailed characterization of TEs modulation in response to HDACIs and suggest the use of HDACIs in combination with ADAR inhibitors to induce cell death and support immunotherapy in cancer.
Insights
Histone deacetylase inhibitors (HDACIs) upregulate endogenous retroviruses (ERVs) in leiomyosarcoma cells, but surprisingly do not activate the interferon response. Increased A-to-I editing of ERV1 may impact dsRNA stability, suggesting combined HDACI and ADAR inhibition for cancer therapy.
Area of Science:
- Cancer Biology
- Immunotherapy
- Epigenetics
Background:
- Transposable elements (TEs), including endogenous retroviruses (ERVs), are investigated for their immunomodulatory potential in cancer therapies.
- TEs can form double-stranded RNAs (dsRNAs) that activate the interferon response, a key component of innate immunity.
- Histone deacetylase inhibitors (HDACIs) are explored for their ability to modulate gene expression, including TEs, in cancer cells.
Purpose of the Study:
- To investigate the effects of different HDAC inhibitors (HDACIs) on TE expression in leiomyosarcoma cells.
- To understand the impact of HDACI-induced TE modulation on the interferon response and potential therapeutic strategies.
Main Methods:
- Treatment of leiomyosarcoma cells with various HDAC inhibitors targeting HDAC1/2/3.
- Analysis of endogenous retrovirus (ERV) expression levels.
- Assessment of interferon response activation.
- Evaluation of A-to-I editing in ERV1 elements.
- Measurement of H3K27ac levels and analysis of associated gene expression, including proapoptotic genes like TNFRSF10B.
Main Results:
- HDAC1/2/3-specific inhibitors upregulated ERVs, particularly ERV1 elements, in leiomyosarcoma cells.
- Contrary to expectations, the interferon response was not activated upon HDACI treatment.
- An increase in A-to-I editing of upregulated ERV1 was observed, potentially affecting dsRNA stability.
- H3K27ac levels increased in LTR12 subfamilies, suggesting a role in regulating proapoptotic gene expression (e.g., TNFRSF10B).
Conclusions:
- HDACIs modulate TE expression in leiomyosarcoma cells, with specific upregulation of ERVs.
- A-to-I editing of ERVs may represent a mechanism to dampen the interferon response, despite TE upregulation.
- Combining HDACIs with ADAR inhibitors could be a viable strategy to induce cancer cell death and enhance immunotherapy.
More Related Videos
Related Concept Videos
Non-LTR Retrotransposons
Mechanisms of Retrovirus-induced Cancers
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation


